Cargando…
Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238734/ https://www.ncbi.nlm.nih.gov/pubmed/32434589 http://dx.doi.org/10.1186/s13058-020-01294-7 |
| _version_ | 1783536589539901440 |
|---|---|
| author | Goldstein, Lori J. Perez, Raymond P. Yardley, Denise Han, Linda K. Reuben, James M. Gao, Hui McCanna, Susan Butler, Beth Ruffini, Pier Adelchi Liu, Yi Rosato, Roberto R. Chang, Jenny C. |
| author_facet | Goldstein, Lori J. Perez, Raymond P. Yardley, Denise Han, Linda K. Reuben, James M. Gao, Hui McCanna, Susan Butler, Beth Ruffini, Pier Adelchi Liu, Yi Rosato, Roberto R. Chang, Jenny C. |
| author_sort | Goldstein, Lori J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7238734 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72387342020-05-29 Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer Goldstein, Lori J. Perez, Raymond P. Yardley, Denise Han, Linda K. Reuben, James M. Gao, Hui McCanna, Susan Butler, Beth Ruffini, Pier Adelchi Liu, Yi Rosato, Roberto R. Chang, Jenny C. Breast Cancer Res Correction BioMed Central 2020-05-20 2020 /pmc/articles/PMC7238734/ /pubmed/32434589 http://dx.doi.org/10.1186/s13058-020-01294-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Goldstein, Lori J. Perez, Raymond P. Yardley, Denise Han, Linda K. Reuben, James M. Gao, Hui McCanna, Susan Butler, Beth Ruffini, Pier Adelchi Liu, Yi Rosato, Roberto R. Chang, Jenny C. Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer |
| title | Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer |
| title_full | Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer |
| title_fullStr | Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer |
| title_full_unstemmed | Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer |
| title_short | Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer |
| title_sort | correction to: a window-of-opportunity trial of the cxcr1/2 inhibitor reparixin in operable her-2-negative breast cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238734/ https://www.ncbi.nlm.nih.gov/pubmed/32434589 http://dx.doi.org/10.1186/s13058-020-01294-7 |
| work_keys_str_mv | AT goldsteinlorij correctiontoawindowofopportunitytrialofthecxcr12inhibitorreparixininoperableher2negativebreastcancer AT perezraymondp correctiontoawindowofopportunitytrialofthecxcr12inhibitorreparixininoperableher2negativebreastcancer AT yardleydenise correctiontoawindowofopportunitytrialofthecxcr12inhibitorreparixininoperableher2negativebreastcancer AT hanlindak correctiontoawindowofopportunitytrialofthecxcr12inhibitorreparixininoperableher2negativebreastcancer AT reubenjamesm correctiontoawindowofopportunitytrialofthecxcr12inhibitorreparixininoperableher2negativebreastcancer AT gaohui correctiontoawindowofopportunitytrialofthecxcr12inhibitorreparixininoperableher2negativebreastcancer AT mccannasusan correctiontoawindowofopportunitytrialofthecxcr12inhibitorreparixininoperableher2negativebreastcancer AT butlerbeth correctiontoawindowofopportunitytrialofthecxcr12inhibitorreparixininoperableher2negativebreastcancer AT ruffinipieradelchi correctiontoawindowofopportunitytrialofthecxcr12inhibitorreparixininoperableher2negativebreastcancer AT liuyi correctiontoawindowofopportunitytrialofthecxcr12inhibitorreparixininoperableher2negativebreastcancer AT rosatorobertor correctiontoawindowofopportunitytrialofthecxcr12inhibitorreparixininoperableher2negativebreastcancer AT changjennyc correctiontoawindowofopportunitytrialofthecxcr12inhibitorreparixininoperableher2negativebreastcancer |